2023-06-27 04:02:59
These low-quality journals, with a peer review of convenience, with publications of articles whose reviewers have asked for rejection, etc. publish a lot of disturbing stuff. Colleagues support these low-quality journals, and thankfully the Deans of Medicine Conference removed MDPI and Frontiers from the whitelist of 3400 non-predatory journals. THE Leonid Schneider’s blog lists some articles from these publishers. These publications of convenience fuel fake news.
Drinking wine decreases cardiovascular disease
Ces article de Nutrients (MDPI) has the title Association between Wine Consumption with Cardiovascular Disease and Cardiovascular Mortality: A Systematic Review and Meta-Analysis“. Interesting info: Received: June 5, 2023 / Revised: June 13, 2023 / Accepted: June 15, 2023 / Published: June 17, 2023. In short, it’s very very good to drink wine, and the results are impressive. This article is the only one in a special issue in which two of the authors are guest editors. You are never better served than by yourself. Here is the translation of part of the summary:
Results: This systematic review included 25 studies, 22 of which were subject to meta-analysis. The pooled RR for the association between wine consumption and risk of coronary heart disease using the DerSimonian and Laird approach was 0.76 (95% CI: 0.69, 0.84), for the risk of cardiovascular disease of 0.83 (95% CI: 0.70, 0.98), and for cardiovascular mortality risk of 0.73 (95% CI: 0.59, 0.90).
Conclusions: This study revealed that wine consumption has an inverse relationship with cardiovascular mortality, cardiovascular disease and coronary heart disease. Age, the proportion of women in the samples and the duration of follow-up did not influence this association. These results should be interpreted with caution, as the increase in wine consumption might be detrimental to people vulnerable to alcohol due to their age, their medication or their pathologies.
Alzheimer soon cured
The International Journal of Molecular Sciences (MDPI) provides information to cure Alzheimer’s. The article is titled Transcranial Electromagnetic Wave Treatment: A Fountain of Healthy Longevity? It took a month to publish Received: 4 May 2023 / Revised: 29 May 2023 / Accepted: 30 May 2023 / Published: 2 June 2023. This is another misleading special issue!! With an impact factor of more than 6… it’s horror!!!
Here is part of the summary: Gerotherapy capable of restoring the immune balance shared by young and middle-aged adults and many centenarians might reduce the risk of these age-related diseases and increase healthy longevity. In this foresight paper, we review potential longevity interventions that are being evaluated and compare them to a novel gerotherapy currently being evaluated in humans, transcranial electromagnetic wave therapy (TEMT). TEMT is delivered non-invasively and safely using a new bio-engineered medical device, the MemorEM, which allows near-total mobility during home treatments. Daily administration of TEMT to patients with mild/moderate Alzheimer’s disease over a period of two months rebalanced 11 of the 12 cytokines present in the blood and brought them back to the level of those of normal-aged adults. Very similar TEMT-induced cytokine rebalancing occurred in CSF/brain for nearly all of the seven measurable cytokines. Overall inflammation in the blood and brain was significantly reduced by TEMT over a 14-27 month period, as shown by C-reactive protein. In these same patients with Alzheimer’s disease, a reversal of cognitive impairment was observed following two months of treatment, while cognitive decline was halted over a 2½-year period of TEMT.
A detail: the authors have the patents to sell their sauce!
1687843329
#Colleagues #support #quality #newspapers #post #trash
